Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
LEGN Legend Biotech
- 33.930
- -0.150-0.44%
Close Dec 23 16:00 ET
- 33.930
- 0.0000.00%
Post 16:00 ET
6.25BMarket Cap-17.67P/E (TTM)
34.540High32.890Low1.62MVolume34.500Open34.080Pre Close54.40MTurnover1.98%Turnover RatioLossP/E (Static)184.29MShares70.13052wk High5.60P/B2.77BFloat Cap32.50052wk Low--Dividend TTM81.77MShs Float77.320Historical High--Div YieldTTM4.84%Amplitude23.410Historical Low33.535Avg Price1Lot Size
Legend Biotech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -24.61%-75.82M | 98.31%-1.65M | 111.15%15.52M | -95.39%-393.28M | -92.28%-95.65M | 15.62%-60.85M | -106.27%-97.57M | -333.34%-139.22M | -1.42%-201.28M | 28.48%-49.74M |
| Net income from continuing operations | -93.43%-120.89M | 90.96%-17.97M | 46.60%-59.79M | -16.69%-520.12M | -8.17%-146.81M | 26.31%-62.5M | -2.99%-198.84M | -248.54%-111.97M | -9.46%-445.72M | -24.15%-135.72M |
| Operating gains losses | 462.04%61.82M | -111.40%-11.65M | -429.40%-49.05M | 1,114.21%114.2M | 299.20%38.36M | 72.23%-17.07M | --102.18M | ---9.27M | -193.51%-11.26M | 133.07%9.61M |
| Depreciation and amortization | 5.82%5.47M | 13.08%5.37M | 10.44%5.72M | 11.20%20.45M | 1.94%5.35M | 1.19%5.17M | --4.75M | --5.18M | 32.15%18.39M | 41.44%5.25M |
| Other non cash items | -119.96%-28.3M | -182.14%-19.9M | -1,069.37%-20.73M | -492.34%-33.3M | -2,525.11%-11.6M | -507.22%-12.87M | -113.48%-7.05M | 96.19%-1.77M | 3,067.48%8.49M | -525.00%-442K |
| Change In working capital | -579.19%-17.39M | 142.26%11.28M | 433.65%106.23M | -139.41%-71.34M | -118.99%-10.25M | -104.66%-2.56M | ---26.7M | ---31.84M | 11.86%181.03M | -8.44%53.98M |
| -Change in receivables | -17.85%12.36M | 34.99%-9.76M | 284,411.76%96.73M | -296.70%-98.98M | -319,416.13%-99.05M | 3,633.00%15.04M | ---15.01M | --34K | 104.64%50.32M | 99.94%-31K |
| -Change in inventory | -41.73%-5.08M | 57.12%-1.39M | -105.71%-4.47M | 8.54%-12.71M | 28.99%-3.7M | -57.86%-3.59M | ---3.25M | ---2.17M | -27,341.18%-13.89M | -4,433.04%-5.21M |
| -Change in prepaid assets | -13,553.47%-13.59M | 24.60%-14.08M | -233.84%-16.27M | 82.76%-8.72M | -118.01%-2.31M | 100.31%101K | ---18.67M | --12.15M | -1,606.47%-50.61M | 1,759.71%12.83M |
| -Change in payables and accrued expense | 17.64%-10.62M | 245.36%36.8M | 171.40%30.18M | -126.87%-51.51M | -116.04%-7.01M | -114.51%-12.89M | --10.65M | ---42.27M | 34.50%191.73M | -39.66%43.69M |
| -Change in other current assets | ---343K | 55.53%-189K | -81.88%77K | -79.43%753K | -72.78%753K | --0 | ---425K | --425K | 411.57%3.66M | 581.04%2.77M |
| -Change in other current liabilities | 102.20%27K | -520.00%-31K | -177.78%-25K | -7.98%-176K | 2,702.44%1.07M | -2,972.50%-1.23M | ---5K | ---9K | -3.16%-163K | 93.11%-41K |
| -Change in other working capital | ---150K | ---- | ---- | 666,766.67%100M | ---- | ---- | ---- | ---2K | 98.58%-15K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -24.61%-75.82M | 98.31%-1.65M | 111.15%15.52M | -95.39%-393.28M | -92.28%-95.65M | 15.62%-60.85M | -13,084.86%-97.57M | -76.92%-139.22M | -1.42%-201.28M | 28.48%-49.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 257.40%329.08M | -471.67%-695.63M | -2,570.98%-396.15M | 220.36%92.79M | 1,534.48%407.51M | -263.48%-209.07M | -121.68M | 16.03M | 60.46%-77.09M | -74.17%24.93M |
| Net PPE purchase and sale | 61.60%-2.07M | 44.36%-3.42M | -47.95%-6.25M | 4.03%-20.08M | 33.69%-4.35M | -108.17%-5.38M | ---6.14M | ---4.22M | 50.40%-20.93M | -261.64%-6.55M |
| Net intangibles purchase and sale | --0 | --0 | --0 | -95.70%-2.64M | -158.41%-2.5M | -110.51%-96K | ---348K | --310K | 57.97%-1.35M | -378.45%-969K |
| Net investment purchase and sale | 295.44%346.56M | -659.84%-675.06M | -901.05%-373.36M | 631.97%213.39M | 1,012.58%432.94M | -235.73%-177.32M | ---88.84M | --46.61M | 72.87%-40.11M | -60.96%38.91M |
| Net other investing changes | 41.34%-15.42M | 34.90%-17.15M | 37.97%-16.54M | -565.60%-97.88M | -187.68%-18.58M | -2,333.15%-26.28M | ---26.35M | ---26.67M | -760.95%-14.71M | ---6.46M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 257.40%329.08M | -471.67%-695.63M | -2,570.98%-396.15M | 220.36%92.79M | 1,534.48%407.51M | -263.48%-209.07M | -4,807.27%-121.68M | 106.90%16.03M | 60.46%-77.09M | -74.17%24.93M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 341.73%4.25M | -99.88%955K | 287.16%831K | 109.40%791.49M | 218.14%925K | -99.75%961K | 790.05M | -444K | -39.68%377.98M | -100.24%-783K |
| Net issuance payments of debt | 32.36%-1.16M | 23.88%-1.16M | 6.88%-758K | -44.65%-3.76M | 121.61%304K | -144.81%-1.72M | ---1.52M | ---814K | -82.95%-2.6M | -233.41%-1.41M |
| Net common stock issuance | --0 | ---- | ---- | 54.56%583.69M | --0 | --0 | ---- | ---- | -39.43%377.64M | --0 |
| Proceeds from stock option exercised by employees | 101.68%5.41M | -98.98%2.12M | 329.46%1.59M | 7,122.84%211.56M | -0.48%621K | 241.66%2.68M | --207.88M | --370K | -36.90%2.93M | 14.92%624K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 341.73%4.25M | -99.88%955K | 287.16%831K | 109.40%791.49M | 218.14%925K | -99.75%961K | 78,200.10%790.05M | -1,876.00%-444K | -39.68%377.98M | -100.24%-783K |
| Net cash flow | ||||||||||
| Beginning cash position | -83.68%201.25M | 35.99%897.57M | 62.55%1.28B | 14.09%786.03M | 18.55%963.47M | 224.72%1.23B | 74.72%660.05M | 14.09%786.03M | 51.19%688.94M | 140.22%812.73M |
| Current changes in cash | 195.74%257.5M | -221.99%-696.33M | -207.21%-379.8M | 392.96%491M | 1,322.17%312.79M | -162.04%-268.96M | 19,899.89%570.8M | 60.27%-123.63M | -57.29%99.6M | -107.30%-25.59M |
| Effect of exchange rate changes | 166.84%524K | -99.62%9K | 85.43%-343K | 127.17%682K | 231.11%1.45M | -43.33%-784K | 373.84%2.37M | -23,640.00%-2.35M | -7,482.35%-2.51M | -1,521.79%-1.11M |
| End cash Position | -52.33%459.28M | -83.68%201.25M | 35.99%897.57M | 62.55%1.28B | 62.55%1.28B | 18.55%963.47M | 224.72%1.23B | 74.72%660.05M | 14.09%786.03M | 14.09%786.03M |
| Free cash flow | -17.44%-77.89M | 95.11%-5.07M | 106.46%9.27M | -86.08%-416M | -78.99%-102.49M | 10.11%-66.32M | -649.88%-103.69M | -82.35%-143.49M | 8.33%-223.56M | 19.33%-57.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
